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CHAPTER I
INTRODUCTION

1.1

Development of a Model Stratum Comeum (SC) Lipid System
The skin is a barrier for most substances entering or leaving the body, and yet selective

permeability for certain molecules, including water molecules, is an essential function of skin
(Scheuplein and Blank, 1971; Downing, 1992; Williams and Barry, 1992). The origin of the
selective permeability of the skin, and its quantitative prediction in terms of the relevant
physical and chemical properties of skin and of penetrating molecules, have been the focal
point for the study of skin permeability (Scheuplein and Blank, 1971; Downing, 1992). The
outermost layer of mammalian skin is the stratum comeum.

The stratum comeum is

composed of about 15 layers of dead cells (comeocytes) in a lipid matrix and consists of 5 to
15 % lipids (dry weight), 75 to 80 % proteins, and 5 to 10 % unknown materials (Williams
and Barry, 1992). Despite their overall small percentage in the stratum comeum, lipids play
an important role in the selective permeability of the skin. Removal of either the entire
stratum comeum or just the lipid component of the stratum comeum in the skin resulted in
similar increases in water flux through the modified skin (Blank, 1952; Onken and Moyer,
1963). In addition, the composition and structural arrangement of stratum comeum lipids
affect topical drug delivery (Hadgraft et al., 1992). The lipid composition of the stratum
comeum is unusual relative to many well-known biological membranes, consisting primarily
of cholesterol, ceramides, free fatty acids and cholesterol sulfate, with little phospholipids
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(Gray et al., 1982; Wertz et al., 1987). Although these lipids form lamellar sheets in intact
stratum comeum (Elias and Friend, 1975; Madison et al., 1987), the stratum comeum
membrane is believed to differ from the vast majority of mammalian cell membranes (Kitson
et al., 1994). A better understanding of the molecular properties of stratum comeum lipids

is critical to studies on the physiology and pathophysiology of the stratum comeum.
Many model systems have been prepared either for studies of the stratum comeum
lipid properties or for studies of lipid - molecule interactions. These model systems include
different dispersions of lipids in water or buffer solutions (Friberg and Osborne, 1985; White
et al., 1988; Kittayanond et al., 1992; Kim et al., 1993a; Mattai et al., 1993; Kitson et al.,
1994), sonicated lipid suspensions, including the preparation of small unilamellar vesicles
(SUVs) (Gray and White, 1979; Wertz et al., 1986; Kittayonand et al., 1992; Blume et al.,
1993; Kim et al., 1993b; Kitagawa et al., 1993), and large unilamellar vesicles (LUVs)
prepared by extrusion methods (Abraham, 1992; Downing et al., 1993). We chose LUVs as
the model system since LUVs were comparatively more stable than the often used but highly
strained, meta-stable SUVs (Szoka, 1987). In addition, the LUV system can be characterized
more quantitatively in terms of lipid concentration, surface area and volume than multilamellar
vesicle (MLV) systems, which are also quite stable. Thus the LUV system, with known
internal volume, lipid concentration, and surface curvature, could be used, for example, in
detailed molecular studies of lipid-molecule interaction, or in quantitative determination of
permeability and transport by stratum comeum lipids.
A variety of lipid compositions have been used in model systems. Although some use
phospholipids as a model of the bilayer structure of the stratum comeum (Kitson et al., 1992),
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most use different mixtures of ceramide, cholesterol, free fatty acid and cholesterol sulfate.
Different ceramides, including epidermal ceramide (Gray and White, 1979; White et al., 1988;
Abraham, 1992; Downing et al., 1993; Kim et al., 1993b) or bovine brain ceramide type Ill
(Kittayanond et al., 1992; Blume et al., 1993; Kitson et al., 1994), type IV (Kitagawa et al.,
1993), or a mixture of bovine brain type III and IV (Mattai et al., 1993), have been used.
Various fatty acids, ranging from camauba fatty acids (used to simulate C20 - C30 fatty acids,
but not commercially available) (Abraham, 1992; Downing et al., 1993), to mixtures of fatty
acids (Friberg and Osborne, 1985; Kim et al., 1993b; Mattai et al., 1993), to just palmitic acid
(Wertz et al., 1986; Kittayanond et al., 1992; Blume et al., 1993; Kim et al., 1993a; Kitagawa
et al., 1993; Kitson et al., 1994) have been used. Thus most of the model systems are
qualitatively similar, but quantitatively very different. No systematic comparison of these
model systems is available. In the first part of this dissertation, the development and
molecular characterization of a model stratum comeum lipid LUV system is described. In
the preparation of our LUVs, we used a lipid composition that was closer to that of the native
system than that used in many of the above mentioned studies. We also used lipids that were
conveniently (commercially) available.

1.2

Molecular Characterization of SC LUVs
In order to characterize our LUVs on the molecular level, we have used both cryo-

and freeze-fracture electron microscopy (EM) to observe the shape of the vesicles, quasi
elastic light scattering (QELS) to determine size distribution, differential scanning calorimetry
(DSC) to obtain thermal transition temperature and spin label electron paramagnetic
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resonance (EPR) techniques to monitor the molecular dynamics of lipids. Many of the
physical techniques that we used have been extensively used in characterizing phospholipid
vesicle systems. However, these techniques have not been applied to stratum comeum lipid
systems until recently (Golden et al., 1987; Hou et al., 1991). Stability of the LUVs at
different pH values was followed. We also demonstrate, by EPR techniques, how this model
system can be used to study partitioning of molecules with slightly different structures (two
different fatty acid derivative spin labels) resulting in very different partitioning in the stratum
comeum lipid vesicles.

1.3

Application of SC LUVs to Study SC Lipid Interactions

In the second part of this dissertation, the SC LUV model lipid system described and
characterized above is used to study the effects of altered lipid composition on lipid
interactions.
In addition to its role in the barrier function of skin, the lipid composition of the
stratum comeum can effect desquamation, i.e. the processes by which comeocytes at the skin
surface detach from neighboring cells and are removed (Brysk and Rajaraman, 1992;
Williams, 1992), leading to disorders of cornification or the processes involved in the
production and maintenance of normal stratum comeum (Williams, 1992).

Lipid

abnormalities have been reported in both common scaling disorders like psoriasis and atopic
dermatitis and inherited disorders like ichthyosis (Williams, 1992). We have incorporated the
lipid modifications present in the diseased skin state, recessive x-linked ichthyosis, in our
model LUV system. Recessive x-linked ichthyosis is clinically characterized by excessive
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scaling of the skin due to prolonged stratum comeum retention (Elias et al., 1984) and
biochemically characterized by a lack of the enzyme steroid sulfatase (Shapiro et al., 1978).
Recessive x-linked ichthyosis is chosen for this study since its lipid modifications are known,
with decreased cholesterol and increased cholesterol sulfate levels in the outer epidermal
layers, the stratum granulosum and the stratum comeum (Williams and Elias, 1981; Elias et
al., 1984). From analysis of human stratum corneum scale from several patients, Williams and
Elias (1981) have reported 2.6 % (by weight) cholesterol sulfate and 15.6 % cholesterol in
normal SC and 14.8 % cholesterol sulfate and 9 % cholesterol in recessive x-linked ichthyosis
SC. The molecular mechanism by which cholesterol sulfate might prevent shedding of the
stratum corneum is still unknown. Cholesterol sulfate is present in the stratum comeum from
2- 5 % and varies amongst different anatomical sites (Lampe et al., 1983). Based on reported
weight percentages of cholesterol and cholesterol sulfate found in the stratum comeum, we
have chosen a 1:5 ratio of cholesterol sulfate:cholesterol to represent normal stratum comeum
and a 1: 1 ratio to represent abnormal stratum comeum. These values closely reflect the fivefold increase in cholesterol sulfate and 50 % decrease in cholesterol found for recessive xlinked ichthyosis scale (Williams and Elias, 1981; Williams, 1992). In addition we have
prepared LUVs without cholesterol sulfate present for comparison with cholesterol sulfatecontaining LUVS.
As discussed earlier, EM studies of intact normal stratum corneum show that the lipids
in this layer of the skin form intact lamellar sheets (Elias and Friend, 1975; Madison et al.,
1987). Thus, in vitro studies involving the interaction of stratum comeum lipids of precise
lipid composition assembled in unilamellar form (LUVs) may be one way to model the in vivo
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physical state of the lipids in the stratum comeum. We have chosen widely used membrane
fusion assays to study lipid interactions. Membrane fusion is defined as a process by which
''the membrane of two lipid vesicles become one and the aqueous contents in them are free
to intermix" (Szoka, 1987). Several assays for monitoring fusion have been developed
recently. A change in vesicle size can be followed by EM, light scattering, gel filtration and
1

H NMR (Szoka, 1987). In addition, several investigators have used assays based on the

release of encapsulated compounds to monitor vesicle content leakage, a process which is
related to fusion kinetically. These leakage assays typically involve monitoring increases in
fluorescence intensity when a fluorophore, which is encapsulated inside vesicles either at
sufficiently high concentrations or with a high enough concentration of quencher molecules
to exhibit intensity quenching, is released from the vesicle and the quenching is relieved due
to concentration dilution.

Examples of leakage systems include the encapsulation of

carboxyfluorescein at a self-quenching concentration inside the vesicles (Weinstein et al.,
1977), or the coencapsulation of a water soluble fluorophore, such as 1-aminonapthalene3, 6, 8-trisulfonic acid (ANTS), and quencher, such as p-xylylenebis(pyridinium) bromide
(DPX) inside the vesicles (Smolarsky et al., 1977; Ellens et al., 1984; Szoka, 1987). Also,
lipid monolayer mixing can be monitored by EPR or by fluorescence methods such as the
resonance energy transfer (RET) assay, where donor and acceptor fluorescent lipid molecules
which are initially in the same vesicles are diluted into unlabeled vesicles. When the bilayers
of the vesicles mix, the surface density of probes is reduced, and the fluorescence intensity
increases (Struck et al., 1981). Additionally, there are assays based on aqueous contents
mixing which involve monitoring enzymatic reactions, chemical complexation or fluorescence
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quenching events which occur when two populations of vesicles containing different
encapsulated materials in their aqueous phases mix their contents (Szoka, 1987). The ANTS/
DPX methodology has also been applied to the aqueous contents mixing assay, where ANTS
and DPX are separately encapsulated in different populations of vesicles. The fluorescence
from ANTS becomes quenched when the aqueous contents of ANTS and DPX vesicles mix
(Ellens et al., 1985).
Investigations have been carried out on the use of vesicles composed of stratum
comeum lipids to study fusion under a variety of different conditions. The majority of these
studies utilized electron microscopy techniques to observe changes in SUVs composed of
various percentages of epidermal ceramides, cholesterol, cholesterol sulfate and free fatty
acids in response to the addition of comeocytes (Abraham and Downing, 1990), salt
(Abraham and Downing, 1990), acylceramides and acylglucosylceramides (Abraham et al.,
1988a and b) and calcium (Abraham et al., 1987). Additionally, calcium effects are also
compared for SUVs prepared with either no free fatty acids or no cholesterol sulfate. The
study with comeocytes and SUVs also monitors carboxyfluorescein leakage (Abraham and
Downing, 1990). In an altogether different type of study, membrane fusion is explored as a
function

of temperature

and

pH

on

a

1: 1: 1

mixture

of

bovine

brain

ceramide:cholesterol:palmitic acid LUVs by freeze fracture EM and the RET assay for bilayer
mixing using phospholipid fluorescent probes (Ahkong et al., 1992). All of these studies did
not focus on the lipid composition of diseased stratum comeum. Also, the studies by
Abraham and coworkers mentioned above, which have cholesterol sulfate in their lipid
composition, did not use LUVs as their model membranes.
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In our studies, we have applied ANTS/DPX fluorescence assays for LUV leakage and
aqueous contents mixing studies. These assays, which have been developed to monitor
changes in phospholipid vesicles (Ellens et al., 1984 and 1985), have not been applied to nonphospholipid based systems in the literature.

Therefore, we have characterized our

ANTS/DPX probe containing SC LUVs for size and size dispersity, ANTS binding to SC
LUVs, and ANTS quenching by DPX. By using well-characterized vesicles in our studies,
we can define the composition and morphology of our system for molecular interpretation of
our results.

The use of both leakage and contents mixing assays allows us to better

understand the bilayer lipid interactions. We have monitored the time-dependent changes in
the fluorescence of probe-containing LUVs in response to addition of calcium and decrease

in pH (from pH 9 to pH 6). We have chosen to monitor pH-induced changes at pH 6 since
the skin surface is slightly acidic. Our results demonstrate lipid composition-dependent
differences in contents mixing and leakage and differences in pH and calcium effects.

CHAPTER II
MATERIALS and METHODS

2.1

Materials
All glassware was acid washed and rinsed with deionized water.

Cholesterol,

cholesterol sulfate, bovine brain ceramides types III and IV (containing alpha-hydroxy acids),
lignoceric acid, octacosanoic acid, and dipalmitoylphosphatidylcholine (DPPC) were
purchased from Sigma Chemical Co. (St. Louis, MO) and palmitic acid was purchased from
Fisher Scientific (Pittsburgh, PA) with at least 99% purity and used without further
purification.

8-Aminonaphthalene-1,3,6-trisulfonic acid disodium salt (ANTS) and p-

xylylenebis(pyridinium) bromide (DPX) were from Molecular Probes, Inc. (Junction City,
OR). Calcium chloride was from Spectrum (Gardena, CA). Other chemicals used to prepare
buffers were purchased from Sigma, Fisher or Calbiochem (La Jolla, CA). Borate buffer from
Fisher, which was labeled as 0.1 M boric acid-KCl-NaOH at pH 9 (Fisher borate buffer), was
used.

2.2

MLVs
The weight percentages of lipids found in the stratum comeum: 55 % ceramides, 25

% cholesterol, 15 % free fatty acids and 5 % cholesterol sulfate (Wertz et al., 1987; Abraham,
1992) were used to prepare MLVs. In this study, we used ceramides types III and IV (3:2
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weight ratio) to represent ceramides, and palmitic, lignoceric, and octacosanoic acids (1:2:1
weight ratio) to represent free fatty acids. The lipids were solubilized in a chloroform and
methanol mixture (2: 1 volume ratio). The solvent was then removed with nitrogen gas
followed by pumping under vacuum overnight to deposit a lipid thin film on a round bottom
flask. Fisher borate buffer (3 ml for 15 mg total lipid) and a few glass beads were added to
the lipid film, followed by hand-swirling, vortexing, and heating to 70 °C in a water bath to
give MLVs at pH 9.

2.3

LUVs
LUVs in Fisher borate buffer were prepared from fresh MLVs by extrusion methods

(Hope et al., 1985) at 70 °C with a lipid extruder (Lipex, Vancouver, B.C. Canada). The lipid
concentrations in MLVs were usually about 5 mg/ml, but higher concentrations, up to 20
mg/ml, were also used. The MLVs were subjected to five freeze-thaw cycles prior to
extrusion (Mayer et al., 1985). Polycarbonate filters (Costar Nucleopore Cambridge, MA)
with 5, 1, 0.4 and 0.1 µm pore sizes were used in the extruder in the order listed (Abraham,
1992) to give stable LUVs at pH 9.
Buffers at different pH values were prepared with osmolality values matching the
value of Fisher borate buffer (150 ± 10 mmol/k:g), measured with a Vapor Pressure 5500
Osmometer (Westcor, Logan, UT). A borate solution (7.5 mM sodium tetraborate, 60 mM
KCl, 0.2 mM EDTA) was prepared and titrated with concentrated HCl to either pH 7.4 or
6.0. Sodium phosphate (72 mM) buffer at pH 7.4 was also prepared.
To better compare the properties ofLUVs at different pH values, LUVs at 10 mg/ml
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were prepared and diluted to about 1 mg/ml with Fisher borate buffer at pH 9. Different
portions (generally 2 ml) of the batch were dialyzed with different buffers (borate at pH 7. 4
or 6, or phosphate buffer at pH 7.4) at 500-fold excess volume. The pH of the LUV solution
inside the dialysis tubing (14K MWCO, from Spectrum Medical Industries, Houston, TX)
was checked, and it was found that about 3 h were needed for pH equilibration with borate
solution and about 1 h with phosphate buffer. The pH values of all LUV samples {-1 mg/ml)
were measured periodically after dialysis, for 24 h. We also measured the pH of LUV
samples after the samples were subjected to freeze/thaw cycles immediately after dialysis.

2.4

Lipid Composition Determination
The lipids in the vesicle suspensions were extracted using chloroform, methanol and

Fisher borate buffer (1:1:1 volume ratio). Potassium chloride (0.1 M) was added to insure
that all cholesterol sulfate was recovered in the chloroform phase (Williams and Elias, 1981).
Additional potassium chloride was added, if necessary, to help separate the phases. The lipid
compositions in the chloroform extracts of MLVs and LUVs were determined by high
performance thin layer chromatography {HPTLC) on silica gel 60 plates {E. M. Separations,
Gibbstown, NJ). The plates (10 x 20 cm) were developed, charred {Melnik et al., 1989) and
scanned with a TLC Scanner II {CAMAG, Muttenz, Switzerland) interfaced to a CR3A
Cromatopac Integrator (Shimatzu Corp., Kyoto, Japan). The peak area of each spot in a
MLV sample was correlated with the known mass of the corresponding lipid in MLVs. This
mass over peak area ratio was then used to convert the peak area of the corresponding LUV
lipid spot to lipid mass. This conversion process was necessary since the lipids used did not
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char to the same extent to give the same linear relationship between spot intensities and
masses for all lipids. The total mass of all the lipids in the LUV sample was obtained from
the sum of individual lipid masses. The value of this sum divided by the total l\1LV lipid mass
represented the recovery of lipid after extrusion. The LUV lipid composition was then
determined from the values of individual and total masses in the LUV sample.

2.5

Vesicle Size
Freeze-fracture and cryo-EM were performed by Northern Lipids Inc. (Vancouver,

B.C. Canada), as a service, on LUVs (20 mg/ml) in Fisher borate buffer at pH 9.
Photon correlation spectroscopy ofQELS measurements with a particle size analyzer
(BI 90; Brookhaven Instruments, New Haven, CT) was used to determine the hydrodynamic
effective diameters of the LUVs in different buffer systems. Immediately after dialysis, LUV
samples (5 - 10 mg/ml) were diluted 2 to 10-fold as necessary to bring the photon count rate
within the recommended range (250-500 kcps) for vesicles with effective diameters of 100 300 nm. At least two different lipid concentrations were used for each sample to show that
the diffusion coefficient of the sample did not change on dilution. Typically 7,500 cycles
(6.25 min) were used. The dust cutoff for the instrument was kept constant for all samples.

If the dust factor in a sample was> 0.02, the measurements were rejected.

For QELS

measurements carried out continuously over 24 h, the LUVs in the cuvette were kept at 25
°C in the instrument throughout the entire measurement period. The sampling time was 25
min (30,000 cycles). Cumulant analysis was applied to scattering data to give effective
diameters and polydispersity. If the polydispersity of an LUV sample was greater than 0.11,
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the QELS measurements of this sample were not used, and the sample was also not used for
preparing LUVs at different pH values.

To further determine whether the diameter

distribution was a broad unimodal or a skewed, multimodal distribution, inverse Laplace
transform analysis, employing an exponential sampling technique, was also used. This
analysis, however, gave a less rigorous analysis of the particle size.

Thus we used the

effective diameter from cumulant analysis as the size of the samples.

2.6

DSC
Lipid thin films, similar to those used for MLVs, were scraped from the walls of a

round bottom flask and sealed in an aluminum sample pan. The sample (3 - 4 mg) was then
equilibrated to 5 °C in a differential scanning calorimeter (DSC 291 O~ Thermal Analysis
Instruments, New Castle, DE). The sample was initially heated from 5 to 90 °C at a rate of
2 °C/min and then cooled back to 5 °C at the same rate. Heat flow (thermogram) was then
recorded during the second heating process. Thermograms were also obtained during the
third cooling and heating processes to determine whether the observed thermal transitions
were reversible. Most samples were used immediately after they were transferred to sealed
sample pans. Some samples remained in the sealed pans for a longer period of time, but less

than 24 h. No differences in the second heating thermograms were observed in samples used.

2.7

Spin Labeled LUVs
Two fatty acid spin probes, 5-doxylstearic acid (5-DSA) and 12-doxylstearic acid

(12-DSA) were purchased from Molecular Probes (Eugene, OR) or Syva (Palo Alto, CA) and
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used without further purification. 5-DSA or 12-DSA in ethanol was dried to a thin film with
a gentle stream of nitrogen gas. A sample ofLUVs at pH 9 was then added to the spin label
thin film at a lipid-to-spin label molar ratio of- 150 to avoid spin-spin exchange (Fung and
Johnson, 1984). The spin label concentrations in samples were generally about 7 - 8 x 10-s
M. The spin label was also directly incorporated into the lipid thin film by adding the spin
label in ethanol to the lipids in chloroform-methanol prior to nitrogen gas evaporation. No
significant spectral differences were found by the two different labeling methods. Samples
of spin labels in borate buffer (- 2 x 1o-s M) were used as controls and were prepared in
tandem with the spin labeled LUV samples.

2.8

EPRMeasurements
EPR measurements were performed using a Varian E-109 EPR Spectrometer

equipped with an IBM variable temperature control unit (Fung and Zhang, 1990). One gauss
modulation, 60 s scan time and 5 mW microwave power were used to obtain EPR spectra.
The EPR cavity with a standard quartz EPR tube filled with silicone fluid to provide thermal
stability was pre-warmed to a desired temperature, which was monitored by a copperconstantan thermocouple (Fung and Zhang, 1990). The spin labeled LUV sample was placed

in the cavity for 2 min before data acquisition to assure thermal equilibration. After each EPR
measurement, the sample was removed from the cavity and placed in a water bath at the same
temperature until the cavity reached a new temperature equilibrium. Temperatures from 25
to 90 °C were used.
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2.9

EPRData Analysis

2.9. I Spectral Subtraction
Spectral subtraction, using commercially available software ASYST (Mac Millan
Software, New York, NY.), modified for EPR operation, was performed to deconvolute the
fast (weakly immobilized) and slow (strongly immobilized) components in spin labeled LUY
spectra (Fig. IA). We were able to use the spectra of spin labels in buffer at matching
temperatures (Fig. IB) to remove the weakly immobilized component in the spectra oflabeled
LUVs at all temperatures studied to give the spectra of the slow component (Fig. IC). A
second subtraction provided the spectra of the fast component. This spectral subtraction
procedure allowed us to use the composite spectra of LUYs to provide pairs of two singlecomponent deconvoluted spectra for more vigorous analysis of spectral parameters, such as
the intensity/concentration of each component in the LUY samples.

2.9.2 Spin Label Intensity
Spectra of a spin label in buffer at different temperatures were obtained, and results
of double integration of the spectra were used to provide calibration curves for spin label
intensity at different temperatures. Such procedures were required to account for differences
in signal intensity due to dielectric-induced changes in cavity sensitivity at different
temperatures (Fung and Johnson, I983). For 5-DSA intensity measurements, the peak height
of the central line of the weakly immobilized component was also used to estimate
concentration since some samples exhibited low signal-to-noise ratio of the weakly
immobilized component signal yielding unreliable double integration results.
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2.9.3

Hyperfine Splitting
The hyperfine splittings (2.Aniax) of the strongly immobilized component in LUV

spectra were measured as the distance between the outermost EPR lines (Griffith and Jost,
1976).

2.9.4 Rotational Correlation Time
The rotational correlation times for the weakly immobilized signal in LUVs and for
the strongly immobilized signal for 12-DSA in LUVs at 90 °C were estimated from line-width
and line height measurements using the linear terms of the motional narrowing theory (Fung
and Johnson, 1984). Approximate axial correlation times (tR) for the remaining strongly
immobilized signals were obtained from the following expression which includes the
temperature dependence of the hyperfine separation measurements (Johnson, 1979):

(1)
For simplicity, we used this equation to estimate the rotational correlation times. Due to
anisotropic averaging, more quantitative calculations of the rotational correlation times should
be obtained with the spectral simulation methods provided by Freed and coworkers (Freed,
1976).

2.9.5 Partition Ratio
The partitioning of fatty acid spin labels in aqueous and lipid phases in LUV samples
was followed as a function of temperature. The fraction of spin labels in the aqueous phase
of LUV samples (fAQUEous) at a particular temperature was obtained from the spin label
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Figure 1

A Typical Example of the Results from Spectral Subtraction of 5-DSA SpinLabeled LUVs into Strongly and Weakly Immobilized Components. Shown
in the figure are EPR spectra at 77 °C of (A) 5-DSA in LUVs in Fisher borate
buffer at pH 9 with a lipid-to-spin label molar ratio of 150 and a spin label
concentration of- 4 x 10-s Mand (B) 5-DSA dispersed in the same buffer. The
weakly immobilized component in (A) was removed by spectral subtraction of (A)
- (B) to give the spectrum of spin label fraction that was intercalated in the lipid
phase ofLUVs (C).
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intensities of deconvoluted spectra of the weakly immobilized signal, and the fraction of spin
labels in the lipid phase (fr.JPm) was obtained from the corresponding spectra of the strongly
immobilized signal.

The ratios of these two fractions (fLIPn/fAQUEous) at a particular

temperature were calculated. This ratio is directly related to the partition coefficient, partial
specific volume oflipid and lipid concentration (Miyazaki et al., 1992).

2.10

Preparation of SC Lipid LUVs Containing ANTS and/or DPX
Multilamellar vesicles (MLVs) and extruded large unilamellar vesicles (LUVs) were

prepared at a lipid concentration of 5 mg/ml for all experiments unless otherwise noted. The
lipid composition of the LUVs was varied as shown in Table 1. Repeated extrusions were
made through the 0.1 µm filters, with frequent filter change as necessary to keep the applied
pressure< 250 psi, until the optical absorbance at 700 nm (A700) was< 0.250. Samples for
leakage and aqueous contents mixing experiments were prepared with ANTS and/or DPX
(Ellens et al., 1984 and 1985). LUVs prepared for the leakage assay contained 12.5 mM
ANTS and 25 mM DPX in Fisher borate buffer at pH 9. An additional 25 mM KCl was
added to maintain an osmolality of-270 mmol/kg. LUVs prepared for the contents mixing
assay contained either (i) 25 mM ANTS or (ii) 50 mM DPX buffered with Fisher borate
buffer at pH 9. Since ANTS is extremely acidic, it was necessary to add a small amount of
NaOH to the solutions containing ANTS in order to bring the pH back up to 9.0. For the
ANTS solution, an additional 52 mM KCl was added and for the DPX solution, an additional
7 mM KCl was added to maintain the solution osmolality at -270 mmol /kg.
To prepare LUVs for ANTS binding experiments, normal lipid composition SC LUVs
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Table 1

Lipid Compositions (Weight%) Used to Make LUVs for Fluorescence Studies

Composition

3

Ceramides•

Cholesterol

Cholesterol
sulfate

Fatty acidsb

55

15

15

15

55

25

5

15

55

30

0

15

•ceramides are composed of a 3 :2 weight ratio of bovine brain ceramides type III and IV,
respectively.
bFatty acids are represented by 1:2:1 (by weight) palmitic:lignoceric:octacosanoic acids.
cThis composition reflects the 1: 1 cholesterol: cholesterol sulfate ratio observed with the
diseased skin state, recessive x-link:ed ichthyosis.
dThis composition reflects the normal distribution of lipids in the stratum comeum and is
designated normal SC LUVs.
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were prepared in Fisher borate buffer at pH 9. DPPC LUVs were also prepared as a control

in pH 9 borate column buffer (30 mM boric acid, 0.2 mM EDTA, - 140 mM KCl titrated to
pH 9 with 1 NNaOH, osmolality-270 mmol/kg) by extrusion at 48 °C through 0.4 and 0.1
µm filters.
For quenching experiments, normal lipid composition SC LUVs were coencapsulated
with 12.5 mM ANTS and either 12.5, 25, or 45 mM DPX in Fisher borate buffer at pH 9.
Additional KCl was added to make the LUVs isosmotic. DPPC LUVs were also prepared
as a control under the same encapsulation conditions at pH 9.
For all LUVs prepared with ANTS and/or DPX solutions, the LUVs were separated
from unencapsulated material by passing 1.5 ml of the mixture through a Sephadex G-75
(Pharmacia, Piscataway, NJ) column (1. 7 cm x 22 cm) equilibrated with borate column buffer.
The LUV peak was eluted from the column in the void volume. Approximately 4.5 ml
associated with the LUV peak were pooled. This diluted sample (-1 mg/ml total lipid) was
used for experiments. Samples were stored, sealed in the dark, until use.

2.11

Lipid Concentration Determination of ANTS/DPX SC LUVs by Cholesterol Oxidase
The cholesterol concentration in the fluorescent probe-containing SC LUV samples

after column separation was determined via the cholesterol oxidase assay (Barenholz et al.,
1978).

A standard curve for determining the cholesterol content was generated using

cholesterol samples with known weights between 1 and 50 µg. Samples were run with and
without cholesterol sulfate present to determine whether cholesterol sulfate interfered with
the assay. Assuming that the decrease in cholesterol concentration reflects the decrease in
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concentration of total lipid, due to the extrusion technique and dilution through the column,
the concentration of total lipid was calculated from the cholesterol concentration in the dilute
sample.

2.12

Lipid Composition of ANTS/DPX SC LUVs
The lipids in 25 mM ANTS LUVs after column elution were extracted into organic

solvent as previously described (Section 2.4). The lipid composition of SC LUVs, containing

0, 5 or 15% cholesterol sulfate with other lipids present in the quantities described in Table
1, was determined by HPTLC on silica gel 60 plates. A control sample (7 mg/ml) containing
1 mg of each of the seven lipids used to make the LUVs was included.

2.13

Vesicle Size Determination of ANTS/DPX LUVs
Quasi-elastic light scattering measurements with cumulant analysis were performed

on encapsulated LUVs to determine effective diameter and polydispersity as described in
Section 2.5.
To investigate the effect of fluorescence probe concentration on SC LUV effective
diameter and polydispersity, normal (5% cholesterol sulfate) SC LUVs encapsulated with

12.5, 25 or 50 mM ANTS and 25, 50, or 90 mM DPX were prepared at pH 9 in borate
buffer. KCl was added to each solution to bring the osmolality to -270 mmol/k:g. After
separation of free ANTS or DPX from the LUVs, the effective diameter and polydispersity
of the preparations were determined by QELS.
To determine whether increased salt concentration affects the effective diameter and
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the polydispersity of SC LUVs, normal SC LUVs in Fisher borate buffer with 60 mM KCl
added (osmolality-255 mmol/k:g) were also prepared for QELS measurements.

2.14

Conditions for Fluorescence Measurements of Binding, Quenching, Contents Mixing
andLeakage
For all experiments, fluorescence was measured with a Hitachi F2000 Fluorescence

Spectrophotometer (Tokyo, Japan) equipped with a circulating water bath set at 25 °C.
Excitation was at 384 nm and emission was measured at 540 nm through a Corning 3-69
cutoff filter to help eliminate the effect of light scattering (Ellens et al., 1984). For all
experiments, 1.5 ml of sample was measured in a stirred cuvette. The shutter was activated
between measurements to help reduce photobleaching. Samples not being measured were
stored in the dark until use and then stirred before measurement.

2.15

Binding of ANTS to LUVs
The binding of ANTS to LUVs (Ellens et al., 1984) was determined by incubating

empty LUVs (5 mg/ml in borate column buffer at pH 9) with 25 mM ANTS, 30 mM boric
acid, 112 mM KCl, and 0.2 mM EDTA buffered at pH 9 in a 1: 1 volume ratio for 1 hour at
room temperature. The LUVs in the mixture were separated from free ANTS on a Sephadex
G-75 column. The fluorescence associated with the LUV peak was measured and compared
to the fluorescence intensity ofLUVs encapsulated with ANTS. The binding experiments
were performed with normal (5% cholesterol sulfate) SC LUVs, and DPPC LUVs run as a
control.
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2.16

Concentration Dependent Quenching of Fluorescence
The quenching of ANTS fluorescence by DPX in LUVs was measured by

coencapsulating 12.5 mM ANTS with 12.5, 25 or 45 mM DPX in LUVS. The fluorescence
intensity of 1.5 ml of LUVs (-1 mg/ml) was measured and designated as the residual
fluorescence. The total fluorescence intensity of 1.5 ml ofLUVs lysed with 0.5% (by vol.)
TritonX-100 was set as 100% (maximal) fluorescence. The quenching was determined as:
(2)

% quenching= 100 - (100 x residual fluorescence/ maximal fluorescence)

Quenching experiments were performed on column separated normal (5% cholesterol sulfate)
SC LUVs and DPPC LUVs at -1 mg/ml.

2.17

Leakage Assay

2.17.1 pH9
The fluorescence intensity of 12.5 mM ANTS/ 25 mM DPX SC LUVs {1.5 ml; -1
mg/ml total lipid) was monitored for 5 hours. Three 5 second readings were averaged
together as one time point measurement.

2.17.2 pH 6
ANTS/DPXLUVs {1.5 ml; -1 mg/ml) were dialyzed for 45 min against a 500-fold
(by volume) excess of2-[N-Morpholino]ethanesulfonic acid (MES) buffer at pH 6 (30 mM
MES, 0.2 mM EDTA, -140 mM KCl, pH 6, osmolality -270 mmol/kg) at ambient
temperature. The contents of the dialysis tubing (14K MWCO from Spectrum Medical
Industries, Houston, TX) were removed and the fluorescence intensity of the sample was
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measured initially and over a five-hour time period. Three 5 second readings were averaged
together for one time point. Alternatively, the pH of normal lipid composition ANTS/DPX
LUVs (pH 9) was lowered by injecting 50 µl of IM MES acid into the LUVs (final
concentration of MES is 33 mM). Time points were taken over a 5-hour time period.

2.17.3 5 mM Ca2+
The fluorescence intensity of ANTS/DPX LUVs (1.5 ml; -1 mg/ml) was measured
at pH 9. To a stirring cuvette ofLUVs, 15 µl of CaC12 solution (0.5 M) was added. The
fluorescence intensity was recorded every 5 seconds for about 2 min and then periodically
over 5 hours.

2.17. 4 Determination of Maximum Fluorescence, Residual Fluorescence, and Leakage
Leakage was measured as % maximum fluorescence where:
(3)

% maximum fluorescence(t)

= 100 x (F(t)-F(O))/(Fmax-F(O))

and F(t) is the fluorescence emission intensity at time t, F(O) is the initial fluorescence
intensity (t = 0 h) designated as residual fluorescence intensity, and F max is the maximum
fluorescence intensity obtained by lysing the vesicles with Triton X-100 (0.5 % by volume)
after the experiment was completed.

2.18

Aqueous Contents Mixing Assay

2.18.1 pH9
ANTS (25 mM) LUVs and DPX (50 mM) LUVs were mixed in a 1: 1 ratio (1.5 ml;
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-1 mg/ml total lipid). The fluorescence intensity of the sample was monitored over 5 hours.

2.18.2 pH 6
ANTS LUVs (0.75 ml) and DPX LUVs (0.75 ml) were separately dialyzed against
a 500-fold excess of MES buffer as stated above for leakage samples. The contents of each
dialysis tubing were mixed, and the fluorescence intensity was monitored initially and over a
five-hour time period. Alternatively, the pH of normal lipid composition ANTS and DPX
LUVs was lowered by injecting 50 µl of 1 MMES acid into 1.5 ml of a 1:1 mixture of ANTS
and DPX LUVs (final concentration of MES is 33 mM). Time points were taken over a 5hour time period.

2.18.3 5 mM Ca2+
ANTS and DPX LUVS were mixed in a 1:1 ratio (1.5 ml; -1 mg/ml total lipid).
Calcium was added to give a 5 mM final concentration and the fluorescence intensity
recorded as described for the leakage samples.

2.18.4 Determination of Aqueous Contents Mixing
Aqueous contents mixing was expressed as % maximum fluorescence where:

(4)

% maximum fluorescence= 100 - (100 x F(t)/F(O))

and F(t) is the fluorescence emission intensity at time t and F(O) is the initial fluorescence
intensity which is designated as the maximum fluorescence.
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2.19

Data Analysis from Fluorescence Assays
Plots of% maximum fluorescence vs. time were generated with the technical graphics

and data analysis program, Origin (Microcal Software, Inc., Northampton, MA).
Approximately three runs of data were acquired for each experimental condition with the
three lipid compositions used. Since data of different runs were not obtained with the same
time points, each run of data was separately best fitted to a randomly selected equation which
resulted in the maximum number of points falling on the curve. With this equation, 101 data
points equally spaced from 0 to 5 h were selected for averaging with other similarly fitted data
points from other runs. These mean values of% F max were plotted as a function of time, with
standard deviations calculated at every 0.5 h. Data points at 0.05 and 0.25 h were also
included to better define the curve during the initial 30 min of measurements. For most of the
conditions, data could be fitted with a four-parameter (Bl> B 2, k 1 and k2) equation:

(5)
where t = time in h.
There were two exceptions to the use of this equation for curve fitting. The data from the
pH 6-induced leakage of SC LUVs containing no cholesterol sulfate could be fitted not by
equation 5, but by a three-parameter (Au, k 1 and k2) equation:
(6)

% Fmax = [Aj(k2-k1)] [k2(e-kit -1) - k1(e-kzt - 1)].

Also the data from the leakage of SC LUVs at pH 9 fit a single parameter equation of the
form:

(7)
All chosen equations allow that% Fmax= 0 when t = 0.

CHAPTER III
RESULTS

3.1

Lipid Composition, Vesicle Size and Stability ofLUVs at pH 9
The lipid composition found in the stratum comeum (Wertz et al., 1987) was used to

prepare MLVs. The HPTLC results ofMLV and LUV lipids (Fig. 2) were very similar. The
two spots at the top of the plate were assigned to free fatty acids (octacosanoic, lignoceric
and palmitic acids), followed by cholesterol, ceramide type III, ceramide type IV and
cholesterol sulfate. Scanning densitometry scans on the charred spots from three separate
preparations showed 80 - 95 % recovery of the MLV lipids in the LUV samples. Thus, the
LUV preparation procedures described above gave relatively high yields of LUVs. In
addition, the lipid compositions ofMLVs and ofLUVs (Table 2) were nearly the same. Little
detectible lipid degradation or loss of specific lipid occurred as a result of either the heating
or the extrusion process used in sample preparation. Thus, the lipid composition of LUVs
was very similar to the one designated to represent stratum comeum lipid composition.
The micrographs ofLUVs at pH 9 using either freeze fracture EM (Fig. 3A) or cryoEM (Fig. 3B) demonstrated, independently, that the LUVs were predominantly spherical with
average diameters of about 100 nm. Some of the vesicles also displayed an angular profile
by both EM techniques, which has been observed in the presence of long, saturated acyl
chains of phospholipid vesicles (Klosgen and Helfrich, 1993; personal communication, T.
28
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Figure 2

High Performance Thin Layer Chromatogram of Stratum Corneum Lipids
in MLVs and LUVs with 50 µ.g Total Lipid for Each Sample. The silica gel
60 plate was first developed with chloroform:methanol:water (95:20: 1 by volume)

to 6.5 cm above the origin and then with hexane:diethyl ether:acetic acid
(80:20: 10 by volume) to -12 cm above the origin. The plate was sprayed with 10
% (w/v) cupric sulfate hydrate in 8 % (w/v) phosphoric acid and charred at

170 °C for 60 min for visualization. The densitometric scan of the MLV lane is

shown on the left. The peak positions are not matched to the spot positions on
the plate due to limited selection on chart speed used for the densitometer. The
identification of each lipid spot was made with similar chromatograms of known
lipid and is shown.
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Table 2

Lipid Composition (Weight Percent, % ) in Multilamellar Vesicles (MLVs), and
in Extruded Large Unilamellar Vesicles (LUVs)

Lipid Type

MLV(%)

LUV(%)

Free Fatty Acid

15•

15.5 ± 1.7i

Cholesterol

25

25.5 ± 1.9

Ceramide III

33

33.2 ± 1.0

CeramideIV

22

20.9 ± 0.9

Cholesterol Sulfate

5

5.0 ± 1.2

Total

100

101

•14 µg of total lipid were used in two runs and 25 µgin the third run.
iAverage weight percent of three different runs.
The intensities of the spots on the HPTLC plate, as shown in Fig. 2, were converted to weight
percent for each lipid type, using MLV spot intensities as reference. See text for details.
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Figure 3

(A) Freeze-Fracture and (B) Cryo-Electron Micrographs of LUVs at
20 mg/ml in Fisher Borate Buffer. The scale bars are 200 run. The vesicles are
generally spherical with a diameter of about 100 run. The micrographs were
prepared, as a service, by Northern Lipids Inc. (Vancouver, Canada).
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Madden, Northern Lipids Inc.). There was a tendency for the vesicles to aggregate at the
high lipid concentrations (20 mg/ml) used for EM measurements.
The average effective diameter from cumulant analysis of QELS measurements of
LUVs obtained from 16 separate LUV preparations, including the 4 different preparations
shown in Table 3, was 119 ± 10 nm with a polydispersity of0.086 ± 0.019. The standard
deviation of 10 nm reported with the average effective diameter was mostly due to slightly
different diameters of LUVs obtained from different LUV preparations. The standard
deviation of multiple QELS measurements on a single LUV sample was equal to or less than
1 nm. Since the majority of the vesicles in micrographs appeared spherical, the effective
diameters obtained from cumulant analysis should be fairly accurate, since the analysis
assumed particles to be spheres. Polydispersity values provided information on the relative
width of the diameter distribution. Samples with values below 0.08 were considered to have
diameters narrowly distributed. Thus, both EM and QELS data showed that the LUVs at pH
9 had shapes similar to spheres with diameters rather narrowly distributed around 100 - 120
nm. These LUVs were also quite stable upon storage at room temperature. The average
effective diameter ofLUVs after 48 h storage remained at about 114 nm with a polydispersity
of 0.076. Inverse Laplace transform analysis showed a single population ofLUVs with a
diameter centered around 116 nm for the time period studied. Thus, the effective diameters
of LUVs remained narrowly centered around 114 nm after 48 h of storage at room
temperature. The LUV samples (1 mg/ml) remained free of precipitation for 4 - 6 weeks,
suggesting that these vesicles were very stable at room temperature.

Table 3 QELS Particle Size Analysis (Using Both Cumulant and Inverse Laplace Transform Analysis Methods) of LUVs in Borate Buffer at Different pH Values
and in Phosphate Buffer at pH 7.4, with Measw-ements Taken Immediately after Dialysis (Top Panel) and 48 h Later (Bottom Panel).
Inverse Laplace transform analysis
Cumulant analysis

Po12ulation 1°

Buffer

pH

ED• (n)

PDb

D (n)

Borate

9

114± 13 (4)

0.091±0.014 (4)

Borate

7.4

117±11 (4)

Borate

6

Pho~hate

4

Po12ulation 2

Fraction(%)°

D (n)

Fraction (%)

116±13(4)

100

NDr

ND

0.137 ± 0.035 (4)

97 ± 26 (4)

32 - 100

226 ± 121 (3)

0-68

128 ± 16 (5)

0.177 ± 0.053 (5)

112 ± 23 (5)

44-100

333 ± 171 (3)

0-56

7.4

133 ±23 P2

0.184 ± 0.042

~32

128±16P2

100

ND

ND

Borate

9

114±13(3)

0.076 ± 0.005 (3)

119 ± 16 (3)

100

ND

ND

Borate

7.4

127 ± 11 (4)

0.165 ± 0.047 (4)

120 ± 15 (4)

76 - 100

796 ± 100 (2)

0 - 24

Borate

6

NA'

NA

NA

NA

NA

NA

Phosphate

7.4

140 ± 13 (3)

0.192 ± 0.042 (3)

116±9(3)

74-82

592 ± 241 (3)

18- 26

w

VI

Table 3 (continued)
"ED is the average effective diameter in nanometers of LUY± SD (n, number of different samples used).
TD is the polydispersity (the relative width of the distribution of ED).
CJ>opulations 1 and 2 represent the two subpopulations identified by the inverse Laplace transformation analysis.
"Dis the center diameter (in nanometers) for each subpopulation ± standard deviation (n, number of samples with the subpopulation).
Traction is the intensity-weighted fraction. The value(%) is shown as a range of values obtained from all samples. For example, for LUVs
in borate buffer at pH 7.4, in population 1, the% for D = 93, 75, 134, and 86 nm were 73, 32, 100, and 42 %, respectively and the
corresponding% in population 2 with D = 366, 146 and 168 nm were 27, 68, and 58 %, respectively.

1ND refers to "not detected".
8NA refers to "not analyzed", due to large amounts of precipitation (large dust factors) in the sample (see Fig 4).

...,

°'
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3.2

Effect of pH on Vesicle Effective Diameter and Polydispersity
Upon decreasing the pH values ofLUV samples, the average effective diameter of

LUVs in borate solution increased slightly, from 114 nm at pH 9, to 117 nm at pH 7.4 and
128 nm at pH 6.0 (Table 3, top panel). The corresponding values for polydispersity increased
from 0.091 to 0.137 and 0.177, respectively. Size distribution results from inverse Laplace
transform analysis also indicated more than one population. The average diameter in each
population exhibited large standard deviations and the intensity-weighted percentages also
varied greatly from run to run, suggesting that the size ofLUVs in borate buffer at pH 7.4 and
6.0 was somewhat heterogeneous and varied from run to run. Upon storage for 48 h, the
LUVs in borate at pH 7.4 further increased their size (127 nm) and heterogeneity
(polydispersity = 0.165) (Table 3, bottom panel). For LUVs at pH 6.0, storage for 48 h
rendered samples with precipitation. Consequently, large dust factors were obtained for
QELS measurements and the data were not analyzed. HPTLC analysis of the precipitated
lipid showed the presence of all lipids, suggesting that the LUVs had fallen apart at pH 6 after
storage at room temperature for 48 h.
We have also followed an LUV sample at pH 6 immediately after preparation with
QELS for about 18 h continuously. As shown in Fig. 4, the effective diameters increased
gradually over 15 h, from 112 nm to about 119 nm. The corresponding polydispersity values
also increased from 0.145 to 0.196. The dust factors in the sample remained around 0.01,
indicating that the sample was still relatively dust-free. After 15 h, the dust factor increased
suddenly to about 0.07 at 16 hand 0.12 at 17 h. The effective diameters and polydispersity
values both dropped, signifying an onset of drastic changes in the LUV sample, which led to
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Figure 4

QELS Particle Size Analysis of LUVs as a Function of Time. (A) Effective
diameter, (B) Polydispersity and (C) Dust Factor, ofLUVs prepared in Fisher
borate buffer at pH 9 (open circles) and then dialyzed in 7.5 mM borate buffer
containing 60 mM KCl and 0.2 mM EDTA at pH 6 (filled circles) are plotted
versus time.

The osmolarity of the buffers was 150 ± 10 mOsm.

QELS

measurements were continuously recorded until the dust factor increased
significantly. The total lipid concentration of the sample was approximately 1.3
mg/ml.

The sample was kept under atmospheric pressure at 25 °C during

measurement. Time zero represents the time when the contents inside the dialysis
tubing reached pH 6.
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the eventual precipitation ofLUVs, as shown in samples after storage for 48 h (Table 3,
bottom panel). As shown in Fig. 4, QELS properties of the control sample (LUVs at pH 9)
remained essentially the same throughout the time period studied.
Since borate buffer has little buffering capacity at pH 7.4 and 6.0, we also dialyzed the
pH 9 LUV samples with phosphate buffer at pH 7.4. The effective diameters ofLUVs in
phosphate buffer were - 15 nm larger than those in borate solution at pH 7.4 (Table 3, top
panel). The polydispersity values increased from 0.137 to 0.184. Inverse Laplace transform
analysis showed one population with an average diameter of 128 nm, in good agreement with
results obtained from the cumulant analysis. Thus the LUVs in phosphate buffer at pH 7.4
appeared to have diameters broadly distributed around 130 nm. Upon storage for 48 h, the
effective diameters appeared to increase slightly, to about 140 nm. Inverse Laplace transform
analysis revealed two populations of different diameters in the LUV samples, with the
majority centered around 120 nm and a minor group centered around 600 nm (Table 3,
bottom panel). These data suggested that the LUVs in phosphate buffer at pH 7.4 were about
10 - 15 nm larger than those at pH 9 and were not as stable as the LUVs at pH 9.
It should be noted that when the LUVs in borate buffer at pH 9 were subjected to
dialysis to pH 7.4 or 6 according to the procedures that we used, the external pH of the LUVs
reached the designated pH value. The internal pH values of the LUVs were not necessarily
the same as the external pH values. Previous studies of phospholipid vesicles prepared in
borate buffer at pH 10.5 and injected into HEPES buffer at pH 7.4 have shown the existence
of pH gradient of - 3 units across the vesicle bilayer for at least 30 min (Wilschut et al.,
1992). It has also been found that borate does not readily permeate phospholipid vesicles
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(Eastman et al., 1989). We performed simple pH measurements on our LUV samples at pH
7.4 in both phosphate and borate buffers. While a 0.05 pH unit increase was noted for LUVs
in borate at pH 7.4, no detectable change in pH was observed for LUVs in phosphate buffer.

For LUVs at pH 6, a 0.40 pH unit increase was measured. Changes similar in pH to those
described above were also measured for LUV samples subjected to freeze/thaw cycles
immediately after dialysis. The buffers and solutions themselves showed no increases in pH
over time. No detectable changes in pH were measured for samples ofLUVs at pH 9. It is
likely that stratum comeum lipid bilayers also exhibit pH gradients similar to those observed
in phospholipid bilayers. More detailed studies are needed for a better understanding of the

pH properties of stratum comeum LUVs prepared at pH 9 and dialyzed to pH 7.4 or 6.

3.3

Thermal Properties of Lipid Mixtures ofLUVs
Second heating thermograms of stratum comeum lipid mixtures with a lipid

composition used for LUV preparation showed two broad, enthalpic transitions centered at
about 60 °C and at 65 °C , with a shoulder at about 70 °C (Fig. 5). These transitions were
also detected in the third heating thermogram, indicating that the enthalpic transitions were
reversible. First heating thermograms of some samples exhibited only one broad transition
instead of a doublet with variations in the temperature at which the transition was centered
(56 - 65 °C). These slight differences could be due to variations in sample preparations,
including moisture contents in lipids.

Regardless of the variation observed in the

thermograms of first heating, the thermograms of the second and third heating were
essentially the same.
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Figure 5

Differential Scanning Calorimetry Thermogram of a Typical Stratum
Corneum Lipid Thin Film Prepared with a Lipid Composition the Same as
that Used to Prepare LUVs. The thermogram represents the second reheat of
the sample at a scan rate of 2 °C/min. The film was evacuated under vacuum
pressure and stored in a closed container until use. Transitions at about 60 and
65 °C were observed.
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Phase transitions for stratum comeum are complex and have been studied by X-ray
diffraction, infrared spectroscopy and DSC techniques. DSC results reported transitions at
35, 65, and 80 °C for intact human stratum comeum and at 60 and 70 °C for porcine stratum
comeum (Golden et al., 1986 and 1987). DSC studies oflipid extracts show a broad lipid
transition at 60 °C for porcine stratum comeum (Golden et al., 1987) and at 65 °C for human
stratum comeum (Golden et al., 1986). These transitions have been attributed to alkyl chain
melting. Our results were in good agreement with published results.

3.4

Dynamic Properties of Lipids in LUVs
The EPR spectra of LUVs labeled with 5-DSA or 12-DSA at pH 9 showed a

composite spectra of weakly and strongly immobilized components at all temperatures.
Typical spectra of 5-DSA and 12-DSA in LUVs at 25 and 90 °C are shown in Fig. 6. As
indicated in the Materials and Method section, the weakly immobilized component spectra
of either 5-DSA or 12-DSA labeled LUV samples at a specific temperature were identical to
spectra of 5-DSA or 12-DSA, respectively, in buffer at the same temperature. At 25 °C, the
rotational correlation time obtained from the spectrum of the spin label in aqueous
environment was approximately 1.3 x 10-10 s for 5-DSA and 1.5 x 1010 s for 12-DSA. At
90 °C, the apparent correlation time was 3.8 x 10-11 s for 5-DSA and 3.7 x 1011 s for 12DSA These rotational correlation time results were in good agreement with published values
for doxylstearic acid spin labels dispersed in buffer (Brown et al., 1981). Thus these spectra
provided evidence that the fatty acid derivative spin labels partitioned into the aqueous phase
as well as into the lipid phase in LUVs.
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Figure 6

Selected EPR Spectra of 5-DSA and 12-DSA in LUVs in Fisher Borate
Buffer at pH 9.

A lipid-to-spin label molar ratio of 150 with a spin label

concentration of 7.5 x 10-s M was used.

Different spin label partitions in the

LUV bilayer and aqueous phases to give different intensities of broad (lipid-like)
and sharp (aqueous-like) signals seen in these spectra at 25 and 90 °C.
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The strongly immobilized EPR signals were those of 5-DSA and 12-DSA intercalated
into the lipid bilayer producing relatively slow motion. A typical spectrum, from spectral
subtraction, of the strongly immobilized (lipid) component of 5-DSA in LUVs at 77 °C is
shown in Fig. IC. 2Au- of the lipid component is proportional to label mobility (Griffith et
al., 1974).

2~ has been used

as an empirical measure of mobility oflipid molecules (Marsh,

1982). The 2Au- of strongly immobilized 5-DSA signals inLUVs at 25 °C was 55.4 ± 1.1
G (n

=

3). The corresponding apparent rotational correlation time was about 1.2 x 10-s s.

The 2Au- of 12-DSA in LUVs at 25 °C was 54.1±3.3 G, with a corresponding apparent
rotational correlation time of about 9.8 x 10-9 s. As the temperature of the samples increased,
2Amax decreased, as expected, for both fatty acid spin labels. However, the quantitative
effects of temperature on 2Au- were different for the two probes. The 2Au- values of 12DSA (Fig. 7B) decrease much faster than those of 5-DSA (Fig. 7A) upon temperature
increase. At 90 °C, 2Au- was 48.9 ± 0.6 G for 5-DSA, corresponding to a rotational
correlation time of about 5.1 x 10·9 s, but was 34.2 ± 1.1 G for 12-DSA, corresponding to
-1.2 x 10·9 s. For 5-DSA, 2Au- was inversely proportional to temperature, and exhibited a
rather linear behavior between 25 and 90 °C. However, for 12-DSA, a gradual, but not
linear, decrease in 2Au- was observed from 25 to 72 °C. The largest change in 21\_ was
observed around 60 °C. Above 72 °C, little change was observed in 2Au-.

3.5

Partitioning of Fatty Acid Spin Labels in LUVs
Since we have demonstrated that both 5-DSA and 12-DSA molecules partition

between lipid and aqueous phases, the intensity ratios of the spin labels in the lipid and in
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Figure 7

Plot of the Hyperfine Splitting of the Strongly Immobilized Component
(2Amax) from the Spectra of (A) 5-DSA (n

= 3) and (B) 12-DSA (n = 2) in

LUVs in Fisher Borate Buffer at pH 9 Versus Temperature. A lipid-to-spin
label molar ratio of 150 with a lipid concentration of 5 mg/ml was used. Note:
vertical scales for the two plots differ since the two spin labels exhibit different
2Amax values. The temperature values given on the top of the plots are round off
values and are not necessarily precise. Data are presented using the bottom
inverse temperature scale.
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the aqueous phases provided quantitative information on the partitioning in stratum comeum
LUVs. When 5-DSA and 12-DSA were introduced to LUVs at pH 9 and 25 °C at a lipid-tospin label ratio of 150, only about 1.0 ± 0.1 % (n=3) of 5-DSA but about 26.0 ± 5.8 % (n =
2) of 12-DSA were in the aqueous phase. At 90 °C, about 4.5 ± 1.2 % of 5-DSA and about
26.3 ± 7.2%of12-DSA were in the aqueous phase. The partition ratio (fr.JPn:/fAQUEous) was
then 96.1 ± 3. 8 for 5-DSA, and only 2.9 ± 0.9 for 12-DSA at 25 °C. At 90 °C, the ratio
decreased to 22.6 ± 5.7 for 5-DSA, whereas the ratio appeared to remain constant for 12DSA (3.0 ± 1.1).
A careful study of the ratios as a function of temperature revealed interesting results.
As shown in Fig. 8A, the average partition ratio (fI.JPII:ifAQUEous) for 5-DSA decreased sharply,

from-96 at 25 °C to -42 at 37 °C and then to -38 at 41 °C. The ratio changed only slightly
from 41 to 50 °C, to a value of-35 at 50 °C. Further increase in temperature in the range
of 5 5 - 70 °C resulted in little change in the ratio values. Above 70 °C, the average ratio
appeared to show a linear relationship with inverse temperature, resulting in a fr.JPn:/fAQUEous
of -23 at 90 °C.
The partition ratio versus temperature plot for 12-DSA (Fig. 8B) was quite different
from that of 5-DSA in the same LUV system at pH 9. The partition ratios decreased slightly
as the temperature was increased from 25 to 40 °C and reached a minimum value of-2 at 40
- 45 °C. Further increase in temperature resulted in slight increase in the partition ratio to -3
at 70 °C. The ratio remained constant as the temperature was further increased to 90 °C.
The results presented in Fig. 8B were average values of two runs. The ratios of one run were
consistently higher (3.5 at 25 °C, for example) than those in the other run (2.3 at 25 °C), by

51

Figure 8

Plot of the Average Partition Ratio (fLIPn/fAQUF.Ous)) of (A) 5-DSA (n

= 3) and

(B) 12-DSA (n = 2) in LUVs in Fisher Borate Buffer at pH 9 as a Function
of Temperature. fr..IPID values were determined from the strongly immobilized
component and fAQUEOus values from the weakly immobilized component. A lipidto-spin label molar ratio of 150 with lipid concentration of 5 mg/ml was used.
Spin label intensity calibration curves was used to determine spin label intensities
at different temperatures. Such procedures were required to account for the
different EPR cavity sensitivity at different temperatures. Note: Vertical scales
for the two plots are different due to large differences in partition values of the
two spin labels. The temperature values given on the top of the plots are round
off values and are not necessarily precise. Data are presented using the bottom
inverse temperature scale.
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about a constant amount throughout the temperature range studied, with the minimum around
40 -45 °C (2.2 for the run with higher values and 0.9 for the run with lower values). Thus,
the temperature-induced changes in the partition coefficients for 12-DSA in LUVs were very
reproducible from run to run, despite the magnitudes of the changes being quite small
(maximum changes were about 1.5).

3 .6

Effect of Salt on Effective Diameter of SC LUVs
LUVs (5 mg/ml) prepared in Fisher borate buffer without fluorescence probes have

an effective diameter of 119 ± 10 nm (n = 16 preparations) and a polydispersity of0.086 ±
0.019 (See page 35). The addition of ANTS and/or DPX results in an increase in osmolality.
Therefore, KCl (-60 mM) was added to Fisher borate buffer in the preparation ofLUVs to
simulate the salt effect when ANTS and DPX were encapsulated in LUVs. The effective
diameter of the LUVs with increased salt was 124 ± 9 nm (n = 2) with a polydispersity of
0.114 ± 0.019. Thus, increasing the salt concentration of the LUVs does not change the
effective diameter of the LUVs.

3. 7

Effect of Fluorescent Probe Concentration on SC LUV Diameter
The effect of probe concentration on the effective diameter and polydispersity of

LUVs is shown in Table 4. When normal SC LUVs were encapsulated with 12.5 or 25 mM
ANTS, little change in effective diameter and polydispersity was observed (i.e. 128 ± 16 nm
with a polydispersity of0.120 ± 0.054 and 120 ± 7 nm with a polydispersity of0.114 ± 0.029,
respectively). These values also agree well with empty SC LUVs prepared in borate buffer.
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Table 4

Effect of Fluorescent Probe Concentration on Normal SC LUVs
ED• (n)

PDb (n)

Encapsulated Probe

Probe Cone. (rnM)

ANTS

50

170 (1)

0.209 (1)

ANTS

25

120 ± 7 (3)

0.114 ± 0.029 (3)

ANTS

12.5

128 ± 16 (2)

0.120 ± 0.054 (2)

DPX

50

121±14 (2)

0.145 ± 0.008 (2)

DPX

25

138 (1)

0.163 (1)

-.ED is the effective diameter in nanometers ofLUVs ±the standard deviation (n, number of
different samples used).
bPD is the polydispersity (the relative width of the distribution).

SS

Thus, encapsulating SC LUVs with ANTS at concentrations less than 25 mM does not effect
the diameter or the distribution of diameters in LUVs. However, encapsulating 50 mM
ANTS in normal SC LUVs resulted in an increase in effective diameter (170 run) and
polydispersity (0.209). The encapsulation ofDPX in normal SC LUVs was more difficult to
achieve than ANTS encapsulation. In general, more than 10 extrusions through 0.1 µm
filters were required to prepare LUVs. The effective diameter (polydispersity) obtained for
SC LUVs encapsulated with 25 mM DPX was 138 run (0.163) and with 50 mM DPX was
121±14 run (0.145 ± 0.008). However, when 90 mMDPX was present in the encapsulation
buffer, vesicles could not be formed. This is in contrast to phosphatidylserine (PS) LUVs
which can be prepared with 90 mM DPX encapsulated (Ellens et al., 1985). Thus for our
fusion experiments, we chose to encapsulate 12.5 mM ANTS and 25 mM DPX in different
compositions of SC LUVs for leakage studies. Additionally, 25 mM ANTS SC LUVs and
50 mM DPX SC LUVs were used for contents mixing studies in order to reduce the effect
of high probe concentrations on LUV size and size distribution.

3.8

Binding of ANTS to LUVs
The fluorescence intensity of normal SC LUVs incubated with 25 mM ANTS and then

column separated was <1 % of the total fluorescence intensity ofLUVs encapsulated with
ANTS. In addition, the effective diameter of the LUVs did not significantly change after
incubation with ANTS (131 versus 135 run in a paired run). The fluorescence intensity of
DPPC LUVs incubated with ANTS and then column separated was also< 1 % of the total
fluorescence intensity of ANTS encapsulated in LUVs. Also, the effective diameter of the
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LUVs did not change after incubation with ANTS (86 run). These results are similar to the
results obtained from empty PS LUVs incubated with 12.5 mM ANTS (Ellens et al., 1985).
Thus, 25 mM ANTS does not significantly interact with SC lipid bilayers and remains in the
aqueous phase inside the vesicles.

3.9

Lipid Composition of ANTS SC LUVs
HPTLC analysis ofLUV lipids from all three lipid compositions used in this study are

shown in Fig. 9. The lipids were extracted from samples containing 25 mM ANTS. Also
shown are lipid standards used to help identify lipids (lane 4). By inspection, as the lipid
composition ofLUVs changes from 0 % cholesterol sulfate (ChS0 4) and 30 % cholesterol
(lane 1) to 5 % cholesterol sulfate and 25 % cholesterol (lane 2) and to 15 % cholesterol
sulfate and 15 % cholesterol (lane 3), the intensities of the spots on the HPTLC plate due to
cholesterol sulfate increased while the intensities of the spots due to cholesterol decreased.
Furthermore, the spots due to the other lipids remained essentially the same. Thus, after
extrusion and column separation, the lipid compositions of the ANTS LUVs were similar to
their starting compositions before extrusion (Table 1).

3.10

Lipid Concentration and QELS Results of SC LUVs Used for Fluorescence Studies
Since the lipid compositions of the dilute SC LUVs were similar to the lipid

composition of the starting materials, the cholesterol concentration of each dilute sample was

used to calculate the concentration of total lipid. The lipid concentration ofLUVs with the
different lipid compositions used for leakage and contents mixing assays are shown in Table
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Figure 9

High Performance Thin Layer Chromatogram of the Lipids from Various
Composition SC LUVs Encapsulated with 25 mM ANTS. The identities of
individual lipids are shown on the right. Lane assignments are as follows: lane 1-

0 % ChS0 4 SC LUVs, lane 2- 5% ChS0 4 SC LUVs, lane 3- 15 %ChS04 SC
LUVs, lane 4- lipid standards with each lipid at a concentration of lmg/ml. About

20 µg total lipid were applied to lanes 1 - 3 and 35 µg total lipid to lane 4.
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fatty acids

cholesterol

ceramide type m
ceramide type IV

cholesterol sulfate

1

2

3

4
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Table 5

QELS Particle Size Analysis and Total Lipid Concentration of Probe
Encapsulated LUVs at pH 9 Used for Leakage and Contents Mixing Assays
%
Cholesterol
sulfate

ED8 (n)

PDb (n)

[Lipidy (n)

25mMANTS

0

119± 35 (2)

0.164 ± 0.064 (2)

1.05 ± 0.36 (3)

50mMDPX

0

154 ± 16 (3)

0.181±0.076 (3)

0. 73 ± 0.46 (3)

12.5 mM ANTS/
25mMDPX

0

124 ± 9 (3)

0.118 ± 0.043 (3)

0.83 ± 0.13 (3)

25mMANTS

5

116 ± 3 (2)

0.100 ± 0.022 (2)

1.30 ± 0.23 (2)

50mMDPX

5

121±14 (2)

0.145 ± 0.008 (2)

0.86 ± 0 (2)

12.5 mM ANTS/
25mMDPX

5

117 ± 20 (3)

0.102 ± 0.048 (3)

1.30 ± 0.29 (3)

25mMANTS

15

105 ± 9 (2)

0.088 ± 0.008 (2)

1.45 ± 0.06 (2)

50mMDPX

15

121±7 (2)

0.137 ± 0.064 (2)

1.14 ± 0.10 (2)

12.5 mM ANTS/
25mMDPX

15

111±6(4)

0.102 ± 0.035 (4)

1.03 ± 0.23 (4)

0-15

121±14 {23)

0.126 ± 0.032 {23)

1.03 ± 0.35 {24)

Encapsulated
Probes

Average

aED is the average effective diameter in nanometers ofLUVs ±the standard deviation (n,
number of different samples used).
11>D is the polydispersity (the relative width of the distribution of ED).
c[Lipid] represents the concentration of total lipid in mg/ml of probe containing LUVs after
column separation. The total lipid concentration is computed by assuming that the cholesterol
concentration (determined via the cholesterol oxidase assay) represents the concentration of
total lipid.
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5 (last column).

The average, mean lipid concentration amongst all of the different

compositions was 1.03 ± 0.35 mg/ml with a range between 0.73 and 1.45 mg/ml.
LUVs used in leakage and contents mixing experiments were also characterized by
QELS. The average effective diameters (polydispersities) ofLUVs prepared with 5 and 15
% cholesterol sulfate ranged from 105 ± 9 run (0.088 ± 0.008) to 121 ± 14 nm (0.145 ±
0.008). In general, the average polydispersity values were slightly higher with 50 mM DPX
encapsulation than with 25 mM ANTS encapsulation for these two lipid compositions (i.e.
0.100 and 0.088 versus 0.145 and 0.137, respectively), indicating that the DPX LUVs had
a broader distribution of effective diameters than the ANTS LUVs. For the LUVs prepared
with 0% cholesterol sulfate, ANTS (25 mM) encapsulation resulted in LUVs with average
effective diameters of 119 ± 35 nm, similar to those obtained for the other lipid compositions.
However, DPX (50 mM) LUVs containing 0% cholesterol sulfate were much more difficult
to prepare and exhibited an average effective diameter of 154 ± 16 run with an average
polydispersity of0.181±0.076. Thus, LUVs encapsulated with DPX were generally larger
than those encapsulated with ANTS, and the distributions of diameters were broader.
Moreover, the inclusion of cholesterol sulfate in the lipid composition partially reduced the
size increase observed with DPX encapsulation.

3.11

Quenching of ANTS Fluorescence by DPX in DPPC and SC LUVs
Since different concentrations of ANTS and DPX were used for leakage and contents

mixing assays with SC LUVs in comparison to published work with phospholipid vesicles
(Ellens et al., 1984 and 1985), it was necessary to determine the extent of quenching in SC
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LUVs under ANTS and DPX concentrations used in our studies. DPPC LUVs were also
tested for comparison with our samples as well as with published phospholipid vesicle data.
The degrees of quenching(% FmaJ of 12.5 mM ANTS by 12.5, 25 and 50 mM DPX in
normal SC LUVs and DPPC LUVs are shown in Fig. 10. Both types ofLUVs displayed
similar quenching profiles. As the DPX concentration in LUVs was increased from 12.5 to
25 mM, the % of ANTS fluorescence quenched by DPX increased from approximately 65 %
to 80 %. Moreover, as the concentration ofDPX was increased to 45 mM, the ANTS
fluorescence was approximately 90 % quenched.

From these quenching profiles, we

demonstrated that ANTS was significantly quenched by DPX at the concentrations used in
our experiments.

3.12

Curve Fitting ofLeakage and Aqueous Contents Mixing Data
The leakage and aqueous contents mixing fluorescence data was fitted to one of three

equations described in the data analysis section of Materials and Methods. An example of
data reproducibility and curve fitting for a leakage experiment is shown in Fig. 11. The
particular example chosen is 5 mM Ca2+-induced leakage of normal lipid composition SC
LUVs. The% maximum fluorescence from three separate experiments (shown as three
different open symbols) is plotted as a function of time. The dotted line through each set of
symbols represents the best fit through the data points. Average values (stars) from the fitted
lines are also shown. For the example chosen, the data was fitted to the four-parameter
double exponential equation previously described. As shown in Fig. 11, the line goes through
most of the data points indicating that the data averaging method that we used (Section 2.19)
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Figure 10 The Quenching of 12.5 mM ANTS by 12.5, 25 and 50 mM DPX in Normal
SC LUVs and DPPC LUVs. Plotted is the% max fluorescence of the sample
that is quenched as a function ofDPX concentration. The closed square symbols
represent SC LUVs and the open circle symbols represent DPPC LUVs.
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Figure 11 An Example of the Variation in Experimental Data and Curve Fitting for 5
mM Ca2+-Induced Leakage of Normal SC LUVs. The three different open
symbols (squares, triangles, and circles) represent three separate runs of data from
different LUV preparations. The dotted line through each curve represents the
best fit through the points. The closed star symbols represent average values from
the three fitted lines.
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is valid.

3.13

Stability of ANTS/DPXLUVs at pH 9
The results of leakage and contents mixing assays of various lipid composition SC

LUVs at pH 9 are shown in Figs. 12 and 13, respectively. These results suggest that leakage
of all SCLUVs (Fig. 12), regardless oflipid composition, is extremely small over 5 hours,
indicating that these LUVs are quite stable at pH 9. In contrast, a slight increase in the
average aqueous contents mixing of the LUVs was observed over 5 h for all lipid
compositions used (Fig. 13). After 5 h, the average contents mixing increased to about 2, 4,
and 5 % for 15, 5 and 0 % cholesterol sulfate-containing LUVs, respectively.

3.14

Stability of ANTS/DPX LUVs at pH 6

3.14.1 Effect ofDifferentLipid Compositions on Leakage at pH 6
The leakage of SC LUVs as a result of dialysis to pH 6 is shown in Fig. 14. For 5
and 15 % cholesterol sulfate-containing LUVs, the pH-induced leakage was similar. LUVs
containing 5 % cholesterol sulfate exhibited about 10 % leakage in the first hour and leveled
off at about 15 % leakage at 5 hours. LUVs containing 15 % cholesterol sulfate exhibited a
similar leakage profile but with slightly reduced levels of leakage; about 7 % leakage was
observed at t = 1 h and about 10 % at t = 5. Since errors of the measurements were relatively
large, it is difficult to quantitatively determine these differences between 5 and 15 %
cholesterol sulfate-containing LUVs. In contrast, the LUVs containing 0 % cholesterol
sulfate exhibited a completely different pH-induced leakage profile (Fig. 14). There appeared
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Figure 12 Leakage of Various Lipid Composition SC LUVs at pH 9. Plotted is the
average fitted data of the% maximum fluorescence as a function of time for 0 %
ChS04 SC LUVs (closed squares, n = 2), 5 % ChS04 SC LUVs (open circles, n
=

3), and 15 % ChS04 SC LUVs(closed triangles, n = 4).
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Figure 13 Aqueous Contents Mixing of Various Lipid Composition SC LUVs at pH 9.
Plotted is the average fitted data of the % maximum fluorescence as a function of
time for 0 % ChS04 SC LUVs (closed squares, n = 4), 5 % ChS04 SC LUVs
(open circles, n = 3), and 15 % ChS04 SC LUVs (closed triangles, n = 3).
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Figure 14 Leakage of Various Lipid Composition SC LUVs at pH 6. Plotted is the
average fitted data of the% maximum fluorescence as a function of time for 0 %
ChS04 SC LUVs (closed squares, n = 3), 5 % ChS04 SC LUVs (open circles, n
=

3), and 15 % ChS04 SC LUVs(closed triangles, n = 4).
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to be a lag phase within the first hour of measurements, where little leakage was observed.
After the first hour, however, leakage increased steadily from about 2 % at t = 1 h to about
36 % at t = 5 h. Thus, after 5 h, these LUVs were considerably less stable than those with
cholesterol sulfate.

3.14.2 Effect of Different Lipid Compositions on Aqueous Contents Mixing at pH 6
The effect of dialyzing SC LUVs from pH 9 to pH 6 on the aqueous contents mixing
of the LUVs is displayed in Fig. 15. All lipid compositions showed similar contents mixing
profiles. The extent of contents mixing within 5 h was greatest for 5 % cholesterol sulfatecontaining LUVs (-16 %). In comparison, 0 and 15 % cholesterol sulfate-containing LUVs
exhibited 12 and 9 % contents mixing, respectively, at t = 5 h. Within the error of the
measurement, it is difficult to determine whether these differences are statistically significant.

3 .14.3 Comparison of pH 6-Induced Leakage and Aqueous Contents Mixing by Dialysis or
Concentrated Acid Injection for Normal SC LUVs
The pH of LUVs for leakage and contents mixing experiments was lowered by dialysis
against an isosmotic buffer at pH 6. An additional set of pH-induced leakage and contents
mixing experiments was performed on SC LUVs containing 5 % cholesterol sulfate. The pH
in these experiments was lowered to 6.0 immediately by injection of concentrated MES acid.
A comparison of the results from the dialysis and injection methods for leakage and contents
mixing are shown in Figs. 16 and 17, respectively. As shown in Fig. 16, over 5 h the LUV
average leakage induced by injection of MES acid slowly increased to 5 % while the average
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Figure 15 Aqueous Contents Mixing of Various Lipid Composition SC LUVs at pH 6.
Plotted is the average fitted data of the % maximum fluorescence as a function of
time for O % ChS04 SC LUVs (closed squares, n = 3), 5 % ChSq SC LUVs
(open circles, n = 3), and 15 % ChS04 SC LUVs (closed triangles, n = 3).
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Figure 16 Comparison of pH 6-Induced Leakage of Normal SC LUVs by Dialysis and
Injection Methods. Plotted is the average fitted data of the % maximum
fluorescence as a function of time for normal SC LUVs lowered from pH 9 to pH
6 by dialysis (open circles, n = 3) and by concentrated MES acid injection (closed
circles, n = 2).
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Figure 17 Comparison of pH 6-Induced Aqueous Contents Mixing of Normal SC
LUVs by Dialysis and Injection Methods. Plotted is the average fitted data of
the % maximum fluorescence as a function of time for normal SC LUVs lowered
from pH 9 to pH 6 by dialysis (open circles, n = 3) and by concentrated MES acid
injection (closed circles, n = 2).
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leakage induced by dialysis increased to about 10 %. However, the variability within the
measurements indicated that these differences might not be significant. Similarly, slight
differences in results were also observed between injection and dialysis methods for pH 6induced contents mixing (Fig. 17). About 13 % contents mixing was observed by the dialysis
method, whereas 18 % was observed by the injection method. Once again , the variability
between the measurements suggested that the differences might not be statistically significant.

3 .15

Effect of Different Lipid Compositions on Leakage Induced by 5 mM Ca2+
The effect of Ca2+ on the leakage of SC LUVs is shown in Fig. 18. Similar leakage

profiles are observed for 5 and 15 % cholesterol sulfate-containing LUVs. Leakage increased
from 0 to 17 % within the first 30 min. Approximately 30 % leakage was observed for the
cholesterol-sulfate containing LUVs within 5 h. In contrast, the Ca2+ -induced leakage of
LUVs with 0 % cholesterol sulfate was initially slower than cholesterol sulfate- containing
samples. About 13 % leakage was observed in the first 30 min. However, the leakage of the
0 % cholesterol sulfate-containing LUVs then increased sharply to about 45 % at t = 5 h.

3 .16

Effect of Different Lipid Compositions on Contents Mixing Induced by 5 mM Ca2+
The effects ofCa2+ on the aqueous contents mixing of all the SC LUVs (Fig. 19) were

similar, regardless of the% cholesterol sulfate present. All SC LUV compositions showed
about 30 % aqueous contents mixing within the first 3 minutes of measurements. This value
leveled off at about 35 % within 1 h. No further changes were observed over the next 4 h.
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Figure 18 Ca2+-Induced Leakage of Various Lipid Composition SC LUVs at pH 9.
Plotted is the average fitted data of the% maximum fluorescence as a function of
time for 0 % ChS04 SC LUVs (closed squares, n = 3), 5 % ChSO 4 SC LUVs
(open circles, n = 3), and 15 % ChS04 SC LUVs(closed triangles, n = 4).
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Figure 19 Ca2+-Induced Aqueous Contents Mixing of Various Lipid Composition SC
LUVs at pH 9. Plotted is the average fitted data of the% maximum fluorescence
as a function of time for 0 % ChS04 SC LUVs (closed squares, n
ChS04 SC LUVs (open circles, n
triangles, n = 3).
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CHAPTER IV

DISCUSSION

4 .1

LUVs as a Model System of SC Lipids
We have described detailed procedures for using lipids that are commercially available

to prepare stratum comeum LUVs at pH 9 by extrusion methods. A model system consisting
of conveniently available lipid components will presumably generate more studies of the
system, leading to a better understanding of stratum comeum lipids on a molecular level. The
experimentally determined lipid composition in LUVs was about 33 % (by weight) ceramide
III, 25 % cholesterol, 21 % ceramide IV, 16 % total free fatty acids and 5 % cholesterol
sulfate, a lipid composition very similar to that of the mammalian stratum comeum. Our LUV
system, which is one of a few model systems using commercially available lipids to include
both ceramide types III and IV, simulates the presence of both alpha-hydroxy and non-alphahydroxy containing ceramides in the stratum comeum. We also used a combination of
commercially available C 16 palmitic, C20 lignoceric, and C28 octacosanoic acids to give a
mixture of fatty acids with C 16 to C28 chain lengths, to closely simulate the free fatty acid
composition in the stratum comeum (Wertz et al., 1987). Thus, we believe that the
combination of the lipids that we used represent a lipid composition very similar to that in
stratum comeum. Our data showed that our LUVs had a relatively uniform size distribution
of about 100 - 120 nm at pH 9 in borate buffer with an osmolality of about 150 mmol/kg.
85
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They were stable at room temperature for at least 4 - 6 weeks. Our DSC data were in good
agreement with published results on lipids extracted from the stratum comeum, indicating that
the lipids in our LUY system were thermodynamically very similar to lipids in intact stratum
comeum. Thus, the advantages of our model system are that ( 1) lipids are easily available,
(2) lipids resemble those in the stratum comeum, both in composition and in thermodynamic
properties, and (3) it is a stable system with well characterized properties, and thus is well
suited for studies of stratum comeum lipid properties under different experimental conditions.
Many phospholipid liposomes have been used as artificial drug carriers (Lasic, 1992).
The requirements for clinical application include: (1) a very narrow size distribution and (2)
long-term stability (Winterhalter and Lasic, 1993). Our LUY system satisfies both of these
requirements, and thus may be suited for further development as carriers for drug or cosmetic
delivery.

4.2

pH Effects on SC LUVs
Since the surface pH of the skin is about pH 5. 5 (Behrendt and Green, 1971; Braun-

F alco and Korting, 1986), model systems that can be used at different pH values will be
useful. Many of the MLV, SUV or lipid dispersion model systems were prepared at neutral
or acidic pH (Friberg and Osborne, 1985; Wertz et al., 1986; Kittayanond et al., 1992; Blume
et al., 1993; Kim et al., 1993a; Kitagawa et al., 1993; Mattai et al., 1993). However, these
systems cannot be characterized as well as LUY systems for quantitative studies. LUVs with
cholesterol sulfate and fatty acids in compositions similar to those found in stratum comeum
were all prepared at pH 8.5 or above (Abraham, 1992; Downing et al., 1993), and are
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reportedly stable for several weeks. Cholesterol sulfate and/or free fatty acids are needed for
lipid systems containing ceramides and cholesterol to form vesicles (Wertz et al., 1986;
Kittayanond et al., 1992). The effective pK. of cholesterol sulfate in membranes is below 4
(Bleau et al., 1974; Kitson et al., 1992). The apparent PK. of fatty acid in membranes is about
7.2 - 7.4 (Ptak et al., 1980). Thus, cholesterol sulfate and free fatty acids are completely

ionized at pH 9. It appears that these charged forms of cholesterol sulfate and fatty acids are
required to form stable vesicles with the lipid composition that we used. In these nonphospholipid, stratum comeum lipid vesicle systems, the precise lipid composition and the pH
of the aqueous environment appear to be critical to the type of vesicle formed and its stability.
In fact, recent 2H NMR studies report that lipid compositions and pH affect the phase
behavior of dispersions containing ceramide and palmitic acid, and in combination with
cholesterol, phase coexistence is common over the temperature range 20 - 75 °C (Kitson et
al., 1994).
As the external pH of the LUVs at pH 9 was lowered to 7.4 and to 6.0 through
dialysis, we observed small, gradual increases in effective diameter and polydispersity, and
these increases continued as the measurements continued as a function of time leading to
unstable vesicles. Since the osmolality of the buffers at different pH values was the same, the
observed changes were attributed to pH changes in the samples. It has been noted that borate
does not readily permeate vesicle bilayers (Hope and Cullis, 1987). A pH gradient across the
bilayer is maintained resulting in lipid asymmetry in vesicles containing phosphatidylcholine
and fatty acids prepared at pH IO and then dialyzed to pH 7 (Wilschut et al., 1992). It is also
possible that, in our non-phospholipid LUY system prepared at pH 9 and dialyzed to pH 7. 4
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or 6.0, a pH gradient was also established between the internal and external aqueous phases
with some of the fatty acids moving preferentially toward the inner leaflet of the lipid bilayer
where they can maintain their negative charge. Consequently, cholesterol sulfate, at relatively
small percentage, was present in the vesicles as the only other negatively charged group in the
outer leaflet of the bilayer, rendering relatively unstable vesicles. At pH 6, the LUVs became
even less stable because the pH was now approaching values below the pK. of fatty acids in
a membrane. In egg yolk phospholipid vesicles, 5-DSA EPR data indicated the co-existence
of both ionized and unionized forms of 5-DSA at pH 6.2 (Egret-Chartier et al., 1978).
Interestingly, the effective diameter of our LUVs at pH 6 increased by only about 20 percent
before precipitation was observed after 15 h. Since the LUV systems at pH< 9 remained
stable for a short period of time, it may be possible to prepare and store LUVs at pH 9, and
later to dialyze the samples to low pH values for molecular studies at pH < 9. When this is
done, QELS data should accompany the molecular studies to insure the integrity of the LUVs
for quantitative interpretation of the data. For example, our QELS data showed that the
LUVs at pH 6 were broadly distributed around 128 nm and remained stable for more than 15
but less than 24 h.

4.3

Dynamic Properties of Lipids in LUVs
Fatty acid spin labels were used to monitor local dynamic properties of the lipid

molecules in the bilayer. 5-DSA reports on motion near the polar headgroup region while 12DSA describes motion in the center of the alkyl chain (Jost et al., 1971; Smith, 1972; Zhang
and Fung, 1994). In phospholipid systems, it is generally accepted that the spin labels are
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randomly distributed between the two membrane bilayer leaflets, although the precise
distribution is not clear. The nitroxide groups on the stearic acids are located near the lipid
molecule head groups, and are closer to the membrane exterior than the analogous position
of the phospholipid acyl chains (Ellena et al., 1988). Our results demonstrate that molecular
motion near the polar headgroup was more restricted than the motion in the alkyl chain region
in the center of the bilayer throughout the temperature range studied (25 - 90 °C). Relatively
smaller temperature-induced increases in motion were observed near the polar headgroup
region than in the center of the alkyl chain. It is interesting to note that 12-DSA reported
rapid changes in motion around 60 °C, a temperature cited as the "melting" of the alkyl chain
by infrared and DSC data (Golden et al., 1987). Above 72 °C, little motional change was
observed in the alkyl chains upon increase in temperature. The motional properties of lipids
in the bilayer depend on molecular packing and molecular interaction among lipid molecules.
When an understanding of the distribution of different lipid molecules in the lipid leaflets is
available, the local motional properties observed by either 5-DSA or 12-DSA can then be
interpreted in more detail.

4.4

Partitioning of Fatty Acid Spin Labels in LUVs
Our results showed that the partitioning of fatty acid derivative molecules (spin labels)

between lipid and aqueous phases was temperature dependent and generally correlated with
the phase transition observed by DSC and the alkyl chain mobility observed by EPR.
However, large differences were observed between 5-DSA and 12-DSA molecules. At 25
°C, when 5-DSA was introduced to the LUV system at pH 9 at a lipid-to-label ratio of 150,
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almost all 5-DSA was in the lipid phase, and only about 1 % of 5-DSA was in the aqueous
phase, with a partition ratio {lipid/aqueous) of 96. However, about 74%of12-DSA was in
the lipid phase, and about 26 % in the aqueous phase, with a partition ratio of about 3.
Partitioning of 5-DSA into the aqueous phase increased upon temperature increase to about
5 % to give a partition ratio of23 at 90 °C. In contrast, for 12-DSA, relatively small changes
in the partitioning of 12-DSA were observed between 25 and 90 °C. Among the small
temperature-induced changes for 12-DSA, a minimum partition coefficient at about 40 °C
was observed.

At this time, no molecular mechanism is obvious for explaining this

phenomena. However, the differences observed between the partitioning of 5-DSA and 12DSA in LUVs at pH 9 can be speculated. 5-DSA and 12-DSA are both derived from stearic
acid, with the plane of the doxyl ring perpendicular to the long axis of the molecule (Broldo
et al., 1982). Thus the only structural difference between these two molecules is the position
of the doxyl spin label moiety, at CS for 5-DSA and C12 for 12-DSA. This small structural
difference produces different polarities for the two molecules.

Since van der Waals

interactions are important in lipid alkyl chain packing, the location of the doxyl spin label on
the alkyl chain is expected to affect the overall polarity and hydrophobicity of the molecules,
and thus affect the partitioning of the molecules in the bilayer. The difference in partitioning
of 12-DSA and 5-DSA has also been noted for phospholipid vesicles (Sentjurc et al., 1990).
It is also interesting to note that the melting point was 51 - 53 °C for 5-DSA and 10 - 12 °C
for 12-DSA {Technical information from Aldridge). Our results suggested that in designing
drug molecules with somewhat polar functional groups (for example, similar to that of the
nitroxide moiety) to be in the stratum comeum lipid phase, it is desirable to attach the
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functional group to a fatty acid molecule close to the headgroup position to provide about 99

% partitioning into the lipid phase.

4.5

Summary of Development and Molecular Characterization of Model LUV System
In summary, we have used commercially available lipids to successfully prepare

relatively stable and well characterized LUVs with lipid compositions and thermodynamic
properties very similar to those in stratum comeum. We also demonstrated the timedependent pH effects on the size and dispersity of the LUVs. Spin label EPR results indicated
more restricted motion near the polar region than near the alkyl chain region. We also
showed that the partitioning of 5-DSA and 12-DSA between LUV lipid and aqueous phases
under similar conditions were quite different from each other. We believe that these results
provide foundations for additional studies of stratum comeum LUVs with other molecules
and/or of LUVs with different lipid composition leading to better understanding of the
physical and functional properties of stratum comeum lipids.

4.6

Characterization of Fluorescent Probe Encapsulated SC LUVs
We are interested in lipid interactions between lamellar bilayers of normal SC lipid

composition and of abnormal SC lipid composition. Therefore, we have investigated lipid
interactions in SC LUVs by vesicle leakage and aqueous contents mixing assays which utilize
ANTS/DPX probes (Ellens et al., 1985). Since the lipid composition of the stratum comeum
contains only trace amounts of phospholipids (Gray et al., 1982; Wertz et al., 1987), it was
necessary to first characterize our non-phospholipid, probe-containing LUVs for lipid
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composition, LUV effective diameter and polydispersity, ANTS binding to lipid bilayers and
ANTS quenching by DPX in LUVs. In contrast to phospholipid vesicles, we found that
LUVs with an effective diameter of about 120 nm in size could not easily be formed with the
high concentrations (above 50 mM) of ANTS and DPX probes used in the aqueous contents
mixing assay.

By preparing several different LUV samples with encapsulated probe

concentrations from 12.5 to 90 mM, we found that the optimum concentration to use for the
leakage assay was 12.5 mM ANTS and 25 mM DPX. Quenching data for ANTS by DPX in
LUVs revealed that these concentrations resulted in -80 % quenching of ANTS by DPX. For
the aqueous contents mixing assay, these values were doubled to 25 mM ANTS and 50 mM
DPX since probes are separately encapsulated in different populations of vesicles and mixed
in a 1:1 (vol.) ratio.
These concentrations, in general, produced LUVs with effective diameters of about
120 nm for the three different lipid compositions containing different levels of cholesterol and
cholesterol sulfate used in our study. The polydispersities of these LUVs were greater than
0.10 but less than 0.16, with higher values near 0.18 obtained for DPX LUVs containing no
cholesterol sulfate. These values suggested that a broader distribution of sizes were present
'

than that observed for LUVs prepared without probes.

The probe effect was further

emphasized by the similar results obtained for LUVs with low (70 mM) and high (130 mM)
KCl concentrations present in the aqueous phase. We found that the osmolality increase
caused by KCl did not produce a change in the effective diameter or the polydispersity of the
LUVs. Instead, it was the difficulty of encapsulating these bulky, charged probes inside the
SC LUVs that resulted in a greater distribution of diameters (i.e. polydispersity). In addition,
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we found that ANTS did not bind to SC lipid bilayers. Furthermore, in spite of the difficulty
of preparing LUVs encapsulated with ANTS and DPX, the lipid composition of the final
LUVs was similar to the starting lipid composition. Thus, we suggested that these LUVs
were suitable for fluorescence leakage and contents mixing assays.

4. 7

Comparison of pH 6-Induced Leakage and Contents Mixing with pH 9 Results
Altering the cholesterol sulfate:cholesterol ratio did not affect the leakage and aqueous

contents mixing at pH 9. The slight% change in leakage (<1 %) and the small change in
aqueous contents mixing (2 - 5 %) suggested that these SC LUVs were relatively stable over
the five-hour experimental period. When the SC LUVs containing 5 or 15 % cholesterol
sulfate and 25 or 15 % cholesterol, respectively, were lowered to pH 6, gradual increases in
leakage and contents mixing were observed over 5 h. The increases were faster over the first
30 min and then gradually increased over the next 4.5 h. LUVs containing 5 % cholesterol
sulfate exhibited slightly more leakage and contents mixing than LUVs containing 15 %
cholesterol sulfate. This suggests that a lower cholesterol sulfate:cholesterol ratio (i.e. 1:5
instead of 1:1) promotes more lipid interactions in LUVs at pH 6. However, variability
between different experimental data with different LUV preparations makes it difficult to
determine whether these results are significantly different. Variability within experimental
data is probably due to slight differences in LUV diameter and lipid concentration. With
phospholipid vesicles, it was found that small changes in the average vesicle size measured
by QELS resulted in significant changes in fusion kinetics (Bentz et al., 1985).

The

destabilization ofLUVs at pH 6 versus pH 9 may be due to the neutralization of the fatty acid
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carbox:ylate group at the surface of the vesicles as has been speculated for the fusion of
phosphatidylethanolamine/oleic acid vesicles at pH 6.

It has been suggested that

neutralization of the fatty acid allows the vesicles to closely approach each other (Duzgunes
et al., 1985). As discussed earlier in this dissertation, we have observed increases in LUV
effective diameter and polydispersity as a function of time in normal lipid composition SC
LUVs when the pH is lowered from 9 to 6 by dialysis. This provides further evidence for the
pH 6-induced destabilization of SC LUVs.
Contents mixing for SC LUVs with no cholesterol sulfate was similar to results
obtained with 5 and 15 % cholesterol sulfate-containing SC LUVs; all compositions resulted
in gradual increases in pH 6-induced contents mixing over time. However, in contrast to
cholesterol sulfate-containing LUVs, the LUVs without cholesterol sulfate showed quite
different leakage profiles. The pH 6-induced leakage of SC LUVs containing no cholesterol
sulfate was initially very slow, with a lag phase over the first hour while the leakage of SC
LUVs containing cholesterol sulfate did not show a 1 h lag phase . However, after 1 h,
leakage of SC LUVs without cholesterol sulfate increased steadily to values significantly
greater than those obtained with cholesterol sulfate-containing LUVs. These results suggest
that SC LUVs containing cholesterol sulfate slowly leak while fusion is occurring at pH 6.
In contrast, SC LUVs without cholesterol sulfate leak after fusion has occurred. This result

was similar to the Ca2+-induced leakage of ANTS and DPX from PS vesicles (Ellens et al.,
1985; Bentz et al., 1985). In this example, fusion was initially non-leaky with massive release
of contents occurring after fusion. These authors suggested that the massive vesicle leakage
after fusion was probably due to the collapse of fused vesicles into anhydrous cochleate
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structures (Wilschut et al., 1980; Ellens et al., 1985).

4.8

Comparison of Ca2+-Induced Leakage and Contents Mixing at pH 9
Ca2+ ( 5 mM} promoted the fusion of all SC LUVs with different levels of cholesterol

and cholesterol sulfate to a greater extent than pH reduction from 9 to 6. In particular, the
Ca2+-induced aqueous contents mixing profile was similar in all three lipid compositions
studied; rapid fusion was observed within the first three min of measurements with little
change over 5 h. The leakage profiles, however, were somewhat slower than those observed
for contents mixing for all three lipid compositions studied. Leakage was slower than
contents mixing with the fastest leakage occurring over the first 30 min. There was no
difference between 5 and 15 % cholesterol sulfate-containing LUVs which suggests that the
that altering the cholesterol sulfate: cholesterol ratio from 1: 5 to 1: 1 does not affect Ca2+induced contents mixing or leakage. However, the presence of cholesterol sulfate in the
LUVs does effect SC LUV leakage. The LUVs with no cholesterol sulfate initially leaked
their contents more slowly than cholesterol sulfate-containing LUVs. After the first 30 min,
however, leakage occurred more rapidly and significantly exceeded values obtained for
cholesterol sulfate-containing SC LUVs. Therefore, it appears that for SC LUVs without
cholesterol sulfate, leakage occurs after fusion, with a massive release of contents after fused
structures collapse similar to pH 6 results.
Our results are in agreement with those obtained by Abraham and coworkers (1987)

which demonstrated that free fatty acids are necessary for Ca2+-induced fusion of vesicles
composed of SC lipids. They used EM techniques to show that SUVs composed of
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cerarnides, cholestero~ and palmitic acid formed lamellar sheets in the presence of Ca2+, while
SUVs composed of cerarnides, cholesterol and cholesterol sulfate did not fuse in the presence
of Ca2+. In addition, Abraham and coworkers found that SUVs composed of ceramides,
cholesterol, palmitic acid and cholesterol sulfate (all present in different percentages than
those used by us) exhibited fusion to larger vesicles and some lamellar sheets in the presence
ofCa2+.

4.9

Speculation on the Physiological Significance of Leakage and Fusion of SC LUVs
Our results demonstrated that altering the cholesterol sulfate: cholesterol weight ratio

of SC LUVs from 5:1 to 1:1 did not significantly effect the contents mixing and leakage
induced by 5 mM Ca2+ addition or a decrease in pH from 9 to 6. This suggests that the
cholesterol sulfate:cholesterol ratio designated to represent recessive x-linked ichthyosis lipid
composition is not by itself enough to prevent SC lipid bilayers from merging and forming
larger structures in vitro. However, our results indicated that the presence of cholesterol
sulfate in SC lipid bilayers affects the way SC lipid vesicles interact with one another.
Whether fusion is induced by low pH or calcium, the leakage of SC LUVs without cholesterol
sulfate was, at first, delayed and then massive. These results suggest that the fusion of SC
LUVs without cholesterol sulfate is non-leaky and then massive due to vesicle collapse.
Thus, the inclusion of cholesterol sulfate in lipid systems for structural and functional studies
of the stratum comeum is important. The possible physiological significance of cholesterol
sulfate in the stratum comeum, as well as other biological membranes, is commented upon
in a recent study by Rodrigueza and coworkers (1995) on the transbilayer movement of
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cholesterol and cholesterol sulfate between liposomal membranes. They find that the rate of
cholesterol sulfate intermembrane exchange is ten-fold faster than cholesterol with the rapidly
exchanging cholesterol sulfate pool located in the outer half of the lipid bilayer. They
comment that since the biological role of cholesterol sulfate is unknown, they cannot say
whether the large difference in exchange kinetics is functionally important in vivo. However,
the increased presence of cholesterol sulfate in the epidermis (Williams, 1992), as opposed
to the lower layers of the skin, suggests that cholesterol sulfate may play an important role
in the structural arrangement of lipids in the stratum corneum. The fact that altering the
cholesterol sulfate:cholesterol levels in our LUVs did not prevent the SC LUVs from coming
together and mixing their aqueous contents suggests that different lipid component(s) are
responsible for the merging of bilayers and mixing of aqueous phases. However, the
differences which we observed in both the pH and Ca 2+-induced leakage of SC LUVs with
and without cholesterol sulfate present indicate that the interaction of lipid components in SC
lipid bilayers is affected by even small quantities of cholesterol sulfate.
The fusion of lipid vesicles is a complicated process. It would be interesting to study
lipid bilayer mixing with the lipid compositions used in this study in order to help elucidate
a mechanism for Ca2+ or pH-induced fusion. For example, the lipid mixing kinetics of
phospholipid vesicles have been compared with contents mixing kinetics in order to increase
understanding of the membrane events accompanying fusion (Duzgunes et al., 1987). In
addition, it would be interesting to study Ca2+-induced fusion at pH 6. Since lowering the pH
from 9 to 6 will affect the surface charge of the outer bilayer ofLUVs, Ca2+-induced leakage
and contents mixing might exhibit a completely different profile. In LUVs composed of
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dioleoylphosphatidylcholine, dioleoylphosphatidylethanolamine, phosphatidylinositol and
dioleoylphosphatidic acid, lipid asymmetry was induced by establishment of a pH gradient,
and differences in Ca2+-induced fusion were observed (Eastman et al., 1992). Finally, since
changing the cholesterol sulfate: cholesterol ratio from 1: 1 and 1:5 did not change the fusion
profile (measured as aqueous contents mixing and leakage) ofLUVs, it would be interesting
to further alter the lipid composition of the vesicles to include either all alpha-OH containing
ceramides or non-alpha-OH containing ceramides and determine the effect of this structural
change on leakage and contents mixing. Since treatment of the skin with alpha hydroxy acids
reduces comeocyte cohesion and promotes a thinner SC (Van Scott and Yu, 1984), altering
the ceramide composition of the SC LUVs in addition to cholesterol sulfate and cholesterol
levels may influence SC vesicle fusion. The importance of stratum comeum ceramide content
and composition in the hereditary ichthyoses has recently been investigated (Paige et al.,
1994).
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